ID
27475
Description
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977
Keywords
Versions (2)
- 11/15/17 11/15/17 -
- 11/26/17 11/26/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 15, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Investigator data Log GSK study Prostatic neoplasms NCT00883909
Investigator data Log GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM
Description
Investigator Comment Log
Description
Investigator’s Statement
Description
Check that the date of signature is on or after the completion of Visit 10.
Data type
date
Description
Sign and date this page after all relevant CRF pages, including outstanding test results, are completed.
Data type
text
Description
Investigator Name
Data type
text
Similar models
Investigator data Log GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM